Post-Operative Atrial Fibrillation
New-onset AF after cardiac surgery (peaks day 2-4)
All Pathways
Cardiothoracic SurgeryManagement
Post-Operative Atrial Fibrillation (STS/AATS 2023)
Post-Operative Atrial Fibrillation (STS/AATS 2023): Post-Operative Atrial Fibrillation → Initial Assessment → Hemodynamically Stable? → ⚠️ Unstable - Ca...
Pathway Overview
12 steps
Algorithm Steps
12 total
01Start 02Action Initial Assessment
Evaluate hemodynamic impact and triggers
- Hemodynamic stability?
- Ventricular rate?
- Duration of AF?
- Symptoms (palpitations, chest pain, dyspnea)?
- Check: electrolytes, volume status, hypoxia, pain
03Decision Hemodynamically Stable?
Adequate BP, perfusion, no acute decompensation
04Warning ⚠️ Unstable - Cardiovert
Synchronized DC cardioversion
- Sedate (propofol, etomidate)
- Synchronized shock 120-200J biphasic
- Consider amiodarone loading after
- Evaluate for underlying cause
05Action Rate Control
First-line for stable POAF
- Target HR <110 bpm (lenient control)
- First-line:
- • Beta-blocker: metoprolol 5mg IV q5min (max 15mg), then 25-100mg PO BID
- • Diltiazem: 0.25 mg/kg IV, then 5-15 mg/hr infusion
- If HFrEF:
- • Amiodarone: 150mg IV over 10min, then 1mg/min x6h, 0.5mg/min x18h
- • Avoid diltiazem/verapamil
06Action Correct Precipitants
Address modifiable factors
- K+ goal >4.0 mEq/L
- Mg2+ goal >2.0 mg/dL
- Optimize volume status
- Treat pain, anxiety
- Address hypoxia
- Wean inotropes/pressors if able
07Decision Consider Rhythm Control?
Rate control often sufficient; rhythm control if:
- Symptomatic despite rate control
- Recurrent AF
- Difficulty with rate control
- Patient preference
08Action Rhythm Control
Pharmacologic cardioversion
- Amiodarone: most effective, preferred in HFrEF
- • Load: 150mg IV, then 1mg/min x6h, 0.5mg/min x18h
- • PO: 400mg BID-TID x7d, then 200mg daily
- Alternatives (preserved EF):
- • Ibutilide 1mg IV over 10min (risk of TdP)
- • Flecainide (avoid if structural HD)
- DC cardioversion if medical therapy fails
09Decision Anticoagulation Needed?
Balance stroke vs bleeding risk
- AF >48h or unknown duration: anticoagulate
- CHA₂DS₂-VASc ≥2: anticoagulate
- Consider bleeding risk post-surgery
- Early post-op: discuss with surgical team
10Action Anticoagulation Strategy
If indicated and safe
- IMMEDIATE post-op (first 24-48h):
- • UFH infusion if high stroke risk
- EARLY post-op (day 2-5):
- • Transition to DOAC when hemostasis assured
- OUTPATIENT:
- • DOAC preferred (apixaban, rivaroxaban)
- • Duration: at least 4 weeks post-discharge
- • Reassess at follow-up (many revert to SR)
11Action Discharge Planning
Outpatient management
- Most POAF resolves within 6-8 weeks
- Continue rate control medications
- Anticoagulation if CHA₂DS₂-VASc ≥2
- Follow-up ECG in 4-6 weeks
- Consider Holter if symptoms
- Cardiology follow-up if persistent
12Outcome Resolution / Ongoing Management
Most convert to sinus rhythm within weeks
- Path rejoins step 11Shared downstream outcome
- Path rejoins step 09Shared downstream outcome
- Path rejoins step 07Shared downstream outcome
- Path rejoins step 05Shared downstream outcome
Guideline Source
STS Clinical Practice Guidelines for Surgical Treatment of Atrial Fibrillation 2023
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Most POAF is self-limiting (resolves within 6-8 weeks)
- Anticoagulation decisions complex in early post-op period
- Drug interactions with post-op medications common
- Does not address AF with hemodynamic instability (see cardioversion)
Applicable Regions
USEU
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Post-Operative Atrial Fibrillation (STS/AATS 2023)?
The Post-Operative Atrial Fibrillation (STS/AATS 2023) is a management clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on STS Clinical Practice Guidelines for Surgical Treatment of Atrial Fibrillation 2023.
What guideline is the Post-Operative Atrial Fibrillation (STS/AATS 2023) based on?
This algorithm is based on STS Clinical Practice Guidelines for Surgical Treatment of Atrial Fibrillation 2023 (DOI: 10.1016/j.athoracsur.2024.01.007).
What are the limitations of the Post-Operative Atrial Fibrillation (STS/AATS 2023)?
Known limitations include: Most POAF is self-limiting (resolves within 6-8 weeks); Anticoagulation decisions complex in early post-op period; Drug interactions with post-op medications common; Does not address AF with hemodynamic instability (see cardioversion). Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Post-Operative Atrial Fibrillation (STS/AATS 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free